// App-Quantinova.ai

: Colorectal liver metastases - novel assessment tools for resectability (The CoNoR Study): results from an international questionnaire of hepatopancreatobiliary surgeons

Researchers

Presenter

  • K. Parmar

Principal Investigators

  • D. O'Reilly

  • R. Jones

  • F. Balaa

  • F. Welsh

  • M. Rees

  • L. Malcomson

  • M. Braun

  • J. Valle

  • A. Renehan

Medical Centers

  • University of Ottowa, Department of Surgery, Canada

  • Manchester University NHS Foundation Trust, Department of Hepatopancreatobiliary Surgery, United Kingdom

  • Basingstoke and North Hampshire Hospital, UK, Department of Hepatopancreatobiliary Surgery, United Kingdom

  • The Christie NHS Foundation Trust, Department of Medical Oncology, United Kingdom

  • University of Manchester, Manchester Cancer Research Centre, United Kingdom

Locations

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Colorectal liver metastases

Biomarkers

  • SRY-Box 10

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final